Europe’s corporate venture space is becoming an increasingly prominent part of the continent’s VC industry. According to our recent 1Q 2017 European Venture Report, CVC deal count in Europe have risen each of the past seven years, even withstanding a 19% YoY dip in overall VC on the continent during 2016. And appetites have remained strong in the first third of the new year.
Since the beginning of 2015, 694 investors have completed at least one CVC deal in Europe, per the PitchBook Platform, with 44% of those 1,219 total investments taking place in the IT sector and another 19% occurring in healthcare. One significant deal in that latter space occurred just last week, when the Novartis Venture Fund, the corporate arm of the Swiss pharma giant, participated in a €37.5 million Series A round for Paris-based Vivet Therapeutics.
Which are the busiest CVCs in the region? Here are the five corporate venture investors to back the most European startups since the beginning of 2015, along with their deal counts (excluding accelerator rounds):